Overview
Gil Verschelden practices in Brussels, Belgium. Mr. Verschelden is rated as an Experienced expert by MediFind in the treatment of Erdheim-Chester Disease. His top areas of expertise are Cerebral Hypoxia, Erdheim-Chester Disease, Lymphofollicular Hyperplasia, and Non-Langerhans-Cell Histiocytosis.
His clinical research consists of co-authoring 9 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Erdheim-Chester Disease.
Locations
Brussels, BRU, Belgium
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cerebral HypoxiaMr. Verschelden isExperienced. Learn about Cerebral Hypoxia.
- COVID-19Mr. Verschelden isExperienced. Learn about COVID-19.
- Erdheim-Chester DiseaseMr. Verschelden isExperienced. Learn about Erdheim-Chester Disease.
- HistiocytosisMr. Verschelden isExperienced. Learn about Histiocytosis.
- Lymphofollicular HyperplasiaMr. Verschelden isExperienced. Learn about Lymphofollicular Hyperplasia.
- Non-Langerhans-Cell HistiocytosisMr. Verschelden isExperienced. Learn about Non-Langerhans-Cell Histiocytosis.